Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Science; 10.1126/science.aah3374.
miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Biochemical and Biophysical Research Communications; doi: 10.1016/j.bbrc.2016.08.037.
Inactivation of Prions and Amyloid Seeds with Hypochlorous Acid
PLOS Pathogens; http://dx.doi.org/10.1371/journal.ppat.1005914.
Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.
PLOS ONE; http://dx.doi.org/10.1371/journal.pone.0164953.
Extended Postnatal Brain Development in the Longest-Lived Rodent: Prolonged Maintenance of Neotenous Traits in the Naked Mole-Rat Brain.
Front Neurosci.; DOI: 10.3389/fnins.2016.00504.
5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors.
ACS Publications; DOI: 10.1021/acs.jmedchem.5b01376.
Structure–activity relationships of radioiodinated diphenyl derivatives with different conjugated double bonds as ligands for α-synuclein aggregates
RSC Advances; DOI: 10.1039/C6RA02710E.
Sensitive analysis of α-synuclein by nonlinear laser wave mixing coupled with capillary electrophoresis
Anal Biochem.; DOI: 10.1016/j.ab.2016.01.010.
Protein Kinase Cδ Upregulation in Microglia Drives Neuroinflammatory Responses and Dopaminergic Neurodegeneration in Experimental Models of Parkinson's Disease.
NCBI; doi: 10.1016/j.nbd.2016.04.008.
Cerebrospinal fluid biomarkers and clinical features in leucine‐rich repeat kinase 2 (LRRK2) mutation carriers..
Mov Disord.; doi: 10.1002/mds.26591..